Surgalign Holdings, Inc., a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is proud to announce the release of HOLO AI Insights.
HOLO AI Insights enables customers, partners, and clinical researchers to take advantage of the Company’s HOLO artificial intelligence (AI) portfolio through a secure, highly scalable cloud platform for automated analysis of medical images. HOLO AI, Surgalign’s portfolio of AI technology, utilizes convolutional neural network technology to automate various tasks such as segmenting medical images, measuring anatomic structures, and planning pedicle screw placement.
As part of Surgalign’s HOLO AI portfolio, HOLO AI Insights analyzes standard protocol lumbar spine MRI images, providing quantitative measurements of 16 different anatomic structures in the spine. Currently, this image processing is being utilized for retrospective data analysis of patient specific medical information from participating sites. The insights generated have the potential for multiple applications in population health, clinical research, and in the future, patient care.
Surgalign has partnered with neuro and orthopedic spine surgeons Hani Malone MD, Greg Mundis MD and Robert Eastlack MD of the San Diego Spine Foundation for the first research deployment of HOLO AI Insights. “More than 90% of patient-generated health data is in the form of unstructured medical imaging data. Transforming this unstructured data into structured datasets of biomarkers, and combining them with patient data such as demographics, comorbidities, clinical data, and patient reported outcome scores, has significant potential to provide new clinical insights,” said Dr. Malone. “I believe that these AI-driven insights can radically augment clinical decision making and ultimately improve patient care.”
“We are very excited to partner with doctors Malone, Mundis and Eastlack in evaluating the potential of HOLO AI. There’s no question that AI is transforming healthcare, and it is Surgalign’s mission to leverage its AI technology to help improve the lives of patients suffering from degenerative or congenital spinal pathologies. The partnership with the San Diego Spine Foundation is a huge leap forward in progressing on that mission,” said Terry Rich, President and Chief Executive Officer of Surgalign.
HOLO AI also powers Surgalign’s HOLO Portal™ surgical guidance system, by automatically segmenting intra-operative 3D images and proposing a plan for surgery. The HOLO Portal system received FDA 510(k) clearance in January of 2022. The addition of HOLO AI Insights is a further step in Surgalign’s mission to transform patient care with artificial intelligence.
HOLO AI Insights is not a medical device and is not intended to be used for patient treatment.